nRichDX Employee Directory

Biotechnology ResearchCalifornia, United States11-50 Employees

nRichDX is a biotechnology company based in Irvine, California, focused on liquid biopsy sample preparation. Its platform aims to recover larger amounts of target analytes, including cfDNA, ctDNA, cfTNA, and cfRNA, than existing preparation methods used in molecular testing. The firm positions itself in the liquid biopsy market as a differentiated, universal solution intended to improve test sensitivity and reliability while streamlining workflow.

Its primary customers are researchers and clinical investigators developing liquid biopsy assays, seeking enhanced assay sensitivity and detection of rare analytes on platforms such as NGS, PCR, and microarrays. The company began technology development in 2016 and introduced its system in late 2018 as a 510K-exempt universal sample prep platform designed to address inaccuracies caused by insufficient target material. In 2023, nRichDX expanded its product line with the Revolution CTC Enrichment Kit for research use, enabling isolation of circulating tumor cells from large-volume blood samples for assay development.

Sign up for free to view info

Company overview Email format